---
figid: PMC4770774__oncotarget-06-39307-g009
figtitle: Stromal cells promote anti-estrogen resistance of breast cancer cells through
  an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma
  3 (Bcl-3) axis
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Equus caballus
- Diaporthe sclerotioides
- Raphanus sativus
- Homo sapiens
- Mus musculus
pmcid: PMC4770774
filename: oncotarget-06-39307-g009.jpg
figlink: /pmc/articles/PMC4770774/figure/F9/
number: F9
caption: Factor(s) secreted by MSCs and CAFs lead to a decline in the IGFBP5 expression.
  The reduced IGFBP5 level results in the release of IGFs from the IGF/IGFBP5 complex
  allowing IGF to activate IGF1R, thereby activating the PI3K/AKT signaling pathway.
  Besides blocking IGF activity by this IGF-dependent function, IGFBP5 also shows
  IGF-independent actions (e.g. as an intracellular protein). Through this IGF-independent
  action IGFBP5 likely keeps Bcl-3 expression down. Consequently, when stromal cells
  downregulate IGFBP5 expression the Bcl-3 expression raises. This leads to fulvestrant
  resistance and to changes in the expression of the Bcl-3 target genes IGF1R, KLHL4
  and SEPP1.
papertitle: Stromal cells promote anti-estrogen resistance of breast cancer cells
  through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma
  3 (Bcl-3) axis.
reftext: Benjamin Leyh, et al. Oncotarget. 2015 Nov 17;6(36):39307-39328.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9669386
figid_alias: PMC4770774__F9
figtype: Figure
organisms_ner:
- Bos taurus
- Equus caballus
- Homo sapiens
- Mus musculus
- Oryctolagus cuniculus
redirect_from: /figures/PMC4770774__F9
ndex: 0bef75d5-deb9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4770774__oncotarget-06-39307-g009.html
  '@type': Dataset
  description: Factor(s) secreted by MSCs and CAFs lead to a decline in the IGFBP5
    expression. The reduced IGFBP5 level results in the release of IGFs from the IGF/IGFBP5
    complex allowing IGF to activate IGF1R, thereby activating the PI3K/AKT signaling
    pathway. Besides blocking IGF activity by this IGF-dependent function, IGFBP5
    also shows IGF-independent actions (e.g. as an intracellular protein). Through
    this IGF-independent action IGFBP5 likely keeps Bcl-3 expression down. Consequently,
    when stromal cells downregulate IGFBP5 expression the Bcl-3 expression raises.
    This leads to fulvestrant resistance and to changes in the expression of the Bcl-3
    target genes IGF1R, KLHL4 and SEPP1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MSC
  - IGFBP5
  - IGF1R
  - PIK3CB
  - AKT1
  - BCL3
  - SELENOP
  - KLHL4
  - SLC25A37
  - IGF1
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - CHMP2A
  - CA9
  - Msc
  - Igfbp5
  - Igf1r
  - Pik3r1
  - Akt1
  - Bcl3
  - Selenop
  - Car9
  - Klhl4
---
